Cardinal Health, Inc. (NYSE:CAH) Holdings Cut by Yousif Capital Management LLC

Yousif Capital Management LLC reduced its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 10.5% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 98,932 shares of the company's stock after selling 11,667 shares during the period. Yousif Capital Management LLC's holdings in Cardinal Health were worth $13,630,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in CAH. Strategic Financial Concepts LLC bought a new stake in Cardinal Health during the 4th quarter valued at $93,000. Wilmington Savings Fund Society FSB boosted its position in Cardinal Health by 2.8% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 7,870 shares of the company's stock valued at $931,000 after buying an additional 211 shares during the period. Kestra Private Wealth Services LLC raised its holdings in Cardinal Health by 23.7% in the 4th quarter. Kestra Private Wealth Services LLC now owns 16,593 shares of the company's stock worth $1,962,000 after purchasing an additional 3,177 shares in the last quarter. Angeles Wealth Management LLC purchased a new stake in Cardinal Health in the fourth quarter worth $205,000. Finally, Essex Financial Services Inc. bought a new stake in shares of Cardinal Health in the 4th quarter worth approximately $213,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

Shares of CAH traded up $0.76 during mid-day trading on Friday, reaching $161.28. 2,722,179 shares of the company's stock were exchanged, compared to its average volume of 2,230,979. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $162.94. The business's fifty day simple moving average is $146.04 and its 200-day simple moving average is $132.69. The stock has a market capitalization of $38.49 billion, a PE ratio of 30.09, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The firm had revenue of $54.88 billion during the quarter, compared to analysts' expectations of $55.33 billion. During the same period in the previous year, the company earned $2.08 EPS. Cardinal Health's revenue for the quarter was up .0% on a year-over-year basis. Equities research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a $0.5107 dividend. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.27%. Cardinal Health's dividend payout ratio (DPR) is 31.83%.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Robert W. Baird lifted their price objective on Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a report on Friday, May 2nd. UBS Group raised their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a report on Tuesday, April 29th. Evercore ISI increased their price objective on shares of Cardinal Health from $175.00 to $180.00 and gave the stock an "outperform" rating in a research report on Thursday. Mizuho lifted their target price on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research report on Monday, March 31st. Finally, Citigroup raised their price target on shares of Cardinal Health from $157.00 to $170.00 and gave the company a "neutral" rating in a report on Friday. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Cardinal Health presently has a consensus rating of "Moderate Buy" and an average target price of $157.43.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.